↓ Skip to main content

A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors

Overview of attention for article published in Nature Communications, October 2022
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (74th percentile)

Mentioned by

twitter
9 X users
facebook
1 Facebook page

Readers on

mendeley
16 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors
Published in
Nature Communications, October 2022
DOI 10.1038/s41467-022-33975-6
Pubmed ID
Authors

Javier Martin-Broto, Andres Redondo, David S. Moura, Claudia Valverde, Jose Manuel Morales, Antonio Lopez-Pousa, Javier Martinez-Trufero, Antonio Gutierrez, Roberto Díaz-Beveridge, Pablo Luna, Virginia Martinez-Marin, David Marcilla, Ivan Arribas, Patricio Ledesma, Jose Antonio Lopez-Martin, Davide Di Lernia, Jorge Zamora, Nadia Hindi

X Demographics

X Demographics

The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 16 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 3 19%
Unspecified 1 6%
Student > Bachelor 1 6%
Other 1 6%
Unknown 10 63%
Readers by discipline Count As %
Medicine and Dentistry 2 13%
Unspecified 1 6%
Nursing and Health Professions 1 6%
Pharmacology, Toxicology and Pharmaceutical Science 1 6%
Unknown 11 69%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 April 2023.
All research outputs
#5,944,903
of 23,597,497 outputs
Outputs from Nature Communications
#35,064
of 49,198 outputs
Outputs of similar age
#111,981
of 446,730 outputs
Outputs of similar age from Nature Communications
#1,565
of 2,154 outputs
Altmetric has tracked 23,597,497 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 49,198 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 56.2. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 446,730 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 2,154 others from the same source and published within six weeks on either side of this one. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.